Browse studies
Find your next paid study
5 recruiting studies matching your filters
Phase 2
Nemolizumab for the Treatment of Lichen Sclerosus
Patients ≥ 18 years of age with Lichen sclerosis (LS)
Lichen Sclerosus of Vulva
Estimated
~$10 – $6,250
University of Texas Southwestern Medical CenterNCT07704775
Phase 3
A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream in Adult Participants With Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period
The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of a…
Lichen Sclerosus
Estimated
~$10 – $8,750
LEO PharmaNCT07335588
Observational
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will b…
Atrophic VaginitisVaginal AtrophyGenitourinary Syndrome of Menopause+3 more
Estimated
~$10 – $8,750
Stratpharma AGNCT05953090
Phase 2
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
We are looking to see if patients using both topical testosterone and estrogen will have a greater improvement in pain with vaginal penetration compared to tho…
VulvodyniaDyspareuniaLichen Sclerosus of Vulva
Estimated
~$10 – $8,750
TriHealth Inc.NCT07260825
Phase 1
A Double Blind Placebo-controlled Trial of StrataMGT for the Management of Vulvar Lichen Sclerosus Symptoms.
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Vulvar Lichen Sclerosus
Estimated
~$10 – $7,500
Andrew T. Goldstein, MDNCT06662942